You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ninlaro

Showing 1 - 25 of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Management Plan Material Utilization Among Pharmacists in Japan

Not yet recruiting
  • Multiple Myeloma
  • No Intervention
  • (no location specified)
May 22, 2023

Multiple Myeloma Trial in Odense (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • Odense, Denmark
    Odense University Hospital
Nov 18, 2021

Human Immunodeficiency Virus (HIV) Trial in Rochester (Ixazomib 1 MG, Ixazomib 2 MG, Ixazomib 3 MG)

Completed
Has Results
  • Human Immunodeficiency Virus (HIV)
  • Ixazomib 1 MG
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Dec 8, 2021

Relapsed and Refractory Multiple Myeloma Trial in Pittsburgh (Mezigdomide, Ixazomib, Dexamethasone)

Not yet recruiting
  • Relapsed and Refractory Multiple Myeloma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Sep 15, 2023

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • No intervention
  • Hefei, Anhui, China
  • +11 more
Jun 22, 2022

Kaposi Sarcoma, Skin Trial in Los Angeles, Saint Louis (Ixazomib Citrate, Quality-of-Life Assessment, Questionnaire

Suspended
  • Kaposi Sarcoma
  • Skin
  • Ixazomib Citrate
  • +2 more
  • San Diego, California
  • +1 more
Jan 30, 2023

Mantle-Cell Lymphoma Trial in United States (Ixazomib, Ibrutinib)

Active, not recruiting
  • Mantle-Cell Lymphoma
  • Atlanta, Georgia
  • +13 more
Nov 17, 2022

Relapsing Remitting Multiple Sclerosis, Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial

Recruiting
  • Relapsing Remitting Multiple Sclerosis
  • +2 more
  • Ixazomib (NINLARO®) capsules / Matching placebo capsules
  • London, Greater London, United Kingdom
    Royal London Hospital, Barts Health NHS Foundation Trust
Feb 17, 2022

Plasma Cell Myeloma Trial in Atlanta (Bortezomib, Daratumumab, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Jan 10, 2023

Plasma Cell Myeloma, Transplant-Related Carcinoma Trial in Seattle (Ixazomib Citrate, Laboratory Biomarker Analysis,

Active, not recruiting
Has Results
  • Plasma Cell Myeloma
  • Transplant-Related Carcinoma
  • Ixazomib Citrate
  • +2 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center
Jul 12, 2022

Multiple Myeloma, Multiple Myeloma in Relapse Trial in Boston (Ixazomib, Pomalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Multiple Myeloma in Relapse
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 13, 2022

Smoldering Multiple Myeloma Trial in Boston (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Smoldering Multiple Myeloma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 15, 2022

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Ann Arbor, Saint Louis (Dexamethasone, Ixazomib,

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Atlanta, Georgia
  • +3 more
Jan 6, 2023

Ninlaro Intensive Drug Monitoring Protocol

Recruiting
  • Multiple Myeloma
  • Neoplasms, Plasma Cell
    • Hefei, Anhui, China
    • +27 more
    Feb 24, 2022

    AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

    Not yet recruiting
    • AL Amyloidosis
    • Venetoclax Oral Tablet, 200 mg
    • +9 more
    • New York, New York
      New York Presbyterian Hospital/Columbia University Irving Medica
    Jul 11, 2022

    Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

    Active, not recruiting
    • Hematopoietic Cell Transplantation Recipient
    • Plasma Cell Myeloma
    • Ixazomib Citrate
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Mar 8, 2022

    Relapsed/Refractory Multiple Myeloma Trial in La Jolla (Ixazomib, Pomalidomide, Dexamethasone)

    Recruiting
    • Relapsed/Refractory Multiple Myeloma
    • La Jolla, California
      UCSD Moores Cancer Center
    Mar 7, 2022

    Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

    Active, not recruiting
    • Plasma Cell Myeloma
    • Daratumumab
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic
    Sep 8, 2022

    Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

    Active, not recruiting
    • Mantle Cell Lymphoma
    • Atlanta, Georgia
    • +1 more
    Oct 26, 2021

    Plasmacytoma, POEMS Syndrome Trial in Rochester (Dexamethasone, Ixazomib Citrate, Lenalidomide)

    Active, not recruiting
    • Plasmacytoma
    • POEMS Syndrome
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    May 26, 2022

    Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma, SMARCB1 Negative Trial in Houston (Doxorubicin,

    Recruiting
    • Metastatic Kidney Medullary Carcinoma
    • +4 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jan 20, 2023

    Recurrent Plasma Cell Myeloma Trial in Rochester (drug, other, biological)

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    May 19, 2022

    Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

    Active, not recruiting
    • Recurrent Plasma Cell Myeloma
    • Refractory Plasma Cell Myeloma
    • Abatacept
    • +3 more
    • Buffalo, New York
    • +2 more
    Dec 22, 2022

    Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

    Active, not recruiting
    Has Results
    • Plasma Cell Leukemia
    • +2 more
    • Rochester, Minnesota
    • +1 more
    May 19, 2022